Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-24

Clinical Trial Update: A Study of Fisetin to Treat Carpal Tunnel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fisetin for carpal tunnel syndrome has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fisetin (fisetin)

Snippet

Sponsor: Peter C. Amadio, M.D. | Conditions: Carpal Tunnel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2025-12-24